Fairfax Financial Holdings Limited
Fairfax Financial Holdings Limited (FRFHF) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Fairfax Financial Holdings Limited (FRFHF), covering cash flow, earnings, and balance sheets.
Fairfax Financial Holdings Limited (FRFHF) Income Statement & Financial Overview
Review Fairfax Financial Holdings Limited FRFHF income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $7.48B | $7.70B | $8.05B | $6.80B |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | -$1.55B |
| Gross Profit | $7.48B | $7.70B | $8.05B | $8.36B |
| Gross Profit Ratio | $1.00 | $1.00 | $1.00 | $1.23 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.82B | $0.00 | $1.29B | $95.70M |
| Operating Expenses | $6.31B | $6.02B | $8.05B | $6.80B |
| Total Costs & Expenses | $6.31B | $6.02B | $8.05B | $5.39B |
| Interest Income | $270.20M | $1.77B | $262.20M | $0.00 |
| Interest Expense | $190.40M | $172.70M | $164.40M | $160.40M |
| Depreciation & Amortization | $291.50M | $217.30M | $226.20M | $152.80M |
| EBITDA | $1.65B | $2.07B | $1.88B | -$313.10M |
| EBITDA Ratio | $0.22 | $0.27 | $0.23 | -$0.05 |
| Operating Income | $1.17B | $1.68B | $0.00 | $1.55B |
| Operating Income Ratio | $0.16 | $0.22 | $0.00 | $0.23 |
| Other Income/Expenses (Net) | $0.00 | $0.00 | $1.49B | -$143.60M |
| Income Before Tax | $1.17B | $1.68B | $1.49B | $1.41B |
| Income Before Tax Ratio | $0.16 | $0.22 | $0.19 | $0.21 |
| Income Tax Expense | $212.70M | $359.30M | $374.50M | $355.40M |
| Net Income | $945.70M | $1.15B | $1.03B | $915.40M |
| Net Income Ratio | $0.13 | $0.15 | $0.13 | $0.13 |
| EPS | $46.10 | $52.31 | $46.60 | $36.68 |
| Diluted EPS | $42.70 | $47.84 | $42.62 | $37.18 |
| Weighted Avg Shares Outstanding | $21.65M | $22.12M | $22.12M | $24.29M |
| Weighted Avg Shares Outstanding (Diluted) | $22.15M | $24.19M | $24.19M | $24.29M |
The company's financials show resilient growth, with revenue advancing from $6.80B in Q2 2024 to $7.48B in Q1 2025. Gross profit remained healthy with margins at 100% in Q1 2025 compared to 123% in Q2 2024. Operating income hit $1.17B last quarter, sustaining a consistent 16% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $1.65B. Net income dropped to $945.70M, while earnings per share reached $46.10. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan